Madrigal Pharmaceuticals (MDGL) EBT Margin (2010 - 2026)

Madrigal Pharmaceuticals' (MDGL) quarterly EBT Margin came in at 29.65% in Q1 2026, up 2372.0% year-on-year from 1.2% in Q1 2025, and up 44.65% on a QoQ basis from 53.56% in Q4 2025.

Madrigal Pharmaceuticals (MDGL) EBT Margin (2010 - 2026) Analysis & Trends

Madrigal Pharmaceuticals (MDGL) has 6 years of EBT Margin data on file, last reported at 29.65% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 2372.0% year-over-year to 29.65% in Q1 2026; TTM through Mar 2026 was 36.88%, a 8223.0% increase from a year earlier, with the FY2025 full-year figure at 89.08%, up 44387.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 29.65%, up from 53.56% in the prior quarter.
  • Over the last five years, EBT Margin for MDGL reached as high as 19.85% in Q2 2025 and fell as low as 1038.2% in Q2 2024.
  • Historically, EBT Margin has averaged 181.21% across 3 years, with a median of 48.87% in 2024.
  • On a YoY basis, EBT Margin climbed as much as 101835 bps in 2025 and fell as far as 919 bps in 2025.
  • Year by year, EBT Margin stood at 44.37% in 2024, then decreased by 21 bps to 53.56% in 2025, then surged by 45 bps to 29.65% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 29.65% in Q1 2026, 53.56% in Q4 2025, and 38.68% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Madrigal Pharmaceuticals 15.77 Bn 15.54 Bn - -29.65%

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.65%
Dec 31, 2025 -53.56%
Sep 30, 2025 -38.68%
Jun 30, 2025 -19.85%
Mar 31, 2025 -53.36%
Dec 31, 2024 -44.37%
Sep 30, 2024 -172.04%
Jun 30, 2024 -1,038.20%
Sep 30, 2012 -30,321.77%
Jun 30, 2012 -20,140.14%
Mar 31, 2012 -10,238.10%
Dec 31, 2011 -9,033.06%
Sep 30, 2011 -757.21%
Jun 30, 2011 -5,866.82%
Mar 31, 2011 -991.86%
Dec 31, 2010 -215.46%
Sep 30, 2010 -303.37%
Jun 30, 2010 -269.17%